CJ CheilJedang Corp
KRX:097950
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/FCFE
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Valuation Scenarios
If P/FCFE returns to its 3-Year Average (10.4), the stock would be worth ₩1 199 048.2 (386% upside from current price).
| Scenario | P/FCFE Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 2.1 | ₩246 500 |
0%
|
| 3-Year Average | 10.4 | ₩1 199 048.2 |
+386%
|
| 5-Year Average | 7.7 | ₩879 660.8 |
+257%
|
| Industry Average | 8.1 | ₩933 216.57 |
+279%
|
| Country Average | 15.1 | ₩1 731 277.01 |
+602%
|
Forward P/FCFE
Today’s price vs future free cash flow to equity
Peer Comparison
| Market Cap | P/FCFE | P/E | ||||
|---|---|---|---|---|---|---|
| KR |
|
CJ CheilJedang Corp
KRX:097950
|
3.9T KRW | 2.1 | -6.9 | |
| JP |
G
|
Goyo Foods Industry Co Ltd
TSE:2230
|
53.2T JPY | -621 880.5 | 540 752.8 | |
| CH |
|
Nestle SA
SIX:NESN
|
203.3B CHF | 28.5 | 22.5 | |
| US |
|
Mondelez International Inc
NASDAQ:MDLZ
|
78.7B USD | 15.9 | 32.1 | |
| FR |
|
Danone SA
PAR:BN
|
42.7B EUR | 15.3 | 23.5 | |
| ZA |
T
|
Tiger Brands Ltd
JSE:TBS
|
47.6B ZAR | 347.5 | 12.5 | |
| US |
|
Hershey Co
NYSE:HSY
|
37B USD | 19.6 | 41.9 | |
| CN |
|
Muyuan Foods Co Ltd
SZSE:002714
|
244.2B CNY | -46.5 | 25 | |
| ZA |
A
|
Avi Ltd
JSE:AVI
|
33.1B ZAR | 16.6 | 12.8 | |
| CN |
|
Foshan Haitian Flavouring and Food Co Ltd
SSE:603288
|
225.7B CNY | 35.9 | 32.1 | |
| CH |
|
Chocoladefabriken Lindt & Spruengli AG
SIX:LISN
|
23.2B CHF | 198.9 | 31.9 |
Market Distribution
| Min | 0.2 |
| 30th Percentile | 8.1 |
| Median | 15.1 |
| 70th Percentile | 28.4 |
| Max | 21 200 |
Other Multiples
CJ CheilJedang Corp
Glance View
CJ CheilJedang Corp., originally founded in 1953 as a sugar manufacturer in South Korea, has evolved into a global powerhouse in the food and bio sectors. The company’s journey began with its efforts to meet post-war food shortages, quickly establishing itself as a staple in Korea's culinary life through its sugar, flour, and cooking oil products. Over the decades, CJ CheilJedang has innovated and diversified its portfolio, becoming a leader in food products both domestically and internationally. This transformation was marked by their expansion into processed foods, instant meals, and health-oriented products, appealing to a wide range of consumer needs. This broad array of offerings is powered by a deep investment in R&D and a keen eye on global food trends, underscoring their agility in pivoting to the demands of a growing global market. Their emphasis on quality and innovation has cultivated a brand synonymous with trust and reliability, extending their reach far beyond the Korean Peninsula. Beyond food, CJ CheilJedang has carved a significant niche in the bioengineering and pharmaceutical sectors. The company's foray into biotechnology positions it strategically at the intersection of science and agriculture, where they produce amino acids and other bio-products that are essential in animal feed and various industrial applications. This diversification is not just an expansion but a strategic alignment with global sustainability trends and the rising demand for bioproducts that are environmentally friendly. By spanning across food production and biotechnology, CJ CheilJedang minimizes risk and enhances its revenue streams, ensuring a resilient business structure. Their integrated approach combines state-of-the-art technology with environmental stewardship, driving its business forward in an increasingly eco-conscious world. Through strategic acquisitions and partnerships, they have fortified their position both vertically and horizontally within the markets they serve, thereby shaping a robust framework for sustained growth.